Nucleophilic alkylation reveals α-radical addition in gem-dichlorocyclobutenones, indicating new synthetic pathways for pharmaceuticals.
Nucleophilic alkylation of gem-dichlorocyclobutenones with alkyl-organometallics is relatively challenging in accessing C(sp³)-enriched α-chlorocyclobutenones. Leveraging single-electron oxidation ability, herein, we report readily accessible alkyltrifluoroborates, enabling a photoinduced SOMOphilic allylic alkylation of gem-dichlorocyclobutenones under metal-free conditions. Additionally, alkene feedstocks are exploited as latent C(sp³) partners in this C(sp³)-C(sp³) bond-forming transformation. This reaction proceeds with high fidelity, expanding the previously limited scope of β-alkyl cyclobutenones beyond β-aryl analogues and enabling access to pharmaceutically relevant scaffolds. Conceptual DFT calculations rationalize the preferential α-radical addition over β-addition, alongside other experimental supports, including an EPR study, for the SET-mediated mechanism.
No takes yet. Share an insight, caveat, or question.
Beck et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: